How the application of artificial intelligence, broader use of real-world evidence, decentralized clinical trials, master protocols, and risk-based quality monitoring, together with strong ethical ...

Secured approval from the Regulation Agency for Medical and Pharmaceutical Activities (RAMPA) in Georgia for Phase 2B/3 ...

With clinical trials under pressure, industry leaders say it’s time for reform, digital transformation, and more patient-centric models.

In this video interview, Heather Horville, solutions consultant at Greenphire, shares how patient advocacy, localized insights, and real-world logistics can help clinical operations teams design ...

Artificial intelligence (AI) should soon be taking a greater role in areas including patient recruitment and in building efficiencies around data quality.

UK & Ireland, experts provided insights on market trends within the clinical trial industry and advice on engagement strategies.

Secured approval from the Regulation Agency for Medical and Pharmaceutical Activities (RAMPA) in Georgia for Phase 2B/3 MIRACLE trial Recent EU approval from the European Medicines Agency (EMA) boosts ...

New data reveals sponsors risk wasting billions by designing overly complex trials and repeatedly recruiting from oversaturated investigator sites Boston, US. 9 July, 2025. Dr. Gen Li, CEO of Phesi, a ...

Substantial clinical need expected to facilitate rapid overall trial enrollmentHOUSTON, July 08, 2025 (GLOBE NEWSWIRE) -- ...

Explore valuable tips and strategies to enhance clinical trials by prioritising and improving the overall patient experience. Learn how to optimise patient recruitment, retention, and satisfaction ...

For decades, clinical trial sponsors relied on second-hand insights from internal experts, physician perspectives and academia to understand the patient’s point of view. Recently, the research ...